Clinical Trial: Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease

U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297316) titled 'Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease' on Dec. 09.

Brief Summary: This study compares the immediate therapeutic and mucin-secreting effects 30 minutes after instillation of 3% diquafosol and 2% rebamipide in dry eye disease.

Study Start Date: Oct. 03, 2022

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease (DED)

Intervention: DRUG: 3% diquafosol (right eye) and 2% rebamipide (left eye)

3% diquafosol was instilled in the right eye and 2% rebamipide in the left eye.

DRUG: 2% rebamipide (right eye) and 3% diquafosol (left eye)

2% rebamipide was instilled in the right eye and 3% diquaf...